Treatment of nonalcoholic fatty liver disease with dapagliflozin in non-diabetic patients

Steatosis, a condition characterized by excessive lipid deposition. Although usually a benign condition, steatosis mays progress to cirrhosis or hepatocellular carcinoma. Recent evidence suggests that SGLT2 inhibitors suppress the development of nonalcoholic steatohepatitis in humans, as well as in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro dos Santos, Lucas, Baer Filho, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424832/
https://www.ncbi.nlm.nih.gov/pubmed/32812927
http://dx.doi.org/10.1016/j.metop.2020.100028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424832/
https://www.ncbi.nlm.nih.gov/pubmed/32812927
http://dx.doi.org/10.1016/j.metop.2020.100028

Ejemplares similares